PharmaGap and MD Biosciences Announce a Collaboration to Pursue Development of a Novel PKC Theta Inhibitor
18-Mar-2009 -
PharmaGap Inc. and MD Biosciences GmbH have entered into a co-development collaboration pertaining to novel compounds for therapeutic usage in inflammatory and neurological applications, including potentially arthritis and multiple sclerosis. MD Biosciences has been granted exclusive access to a ...
arthritis
inflammation
inhibitors
+4